Multicenter study on atypical femoral fractures in patients with bone metastases taking bone- modifying agents

Bone-modifying agents (BMAs), with bone-resorptive inhibitory effects, such as zoledronic acid and denosumab, are widely used at higher doses for bone-related events caused by bone metastasis of malignant tumors. These drugs have been suggested to be associated with atypical femoral fractures (AFFs)...

Descripción completa

Detalles Bibliográficos
Autores principales: Fukui, Tomoaki, Oe, Keisuke, Kawamoto, Teruya, Morishita, Masayuki, Fujita, Ikuo, Takahara, Shunsuke, Sakurai, Atsushi, Iwakura, Takashi, Yoshida, Keiji, Ito, Kenjiro, Shoda, Etsuo, Hiranaka, Takafumi, Tsunoda, Masaya, Kuroda, Ryosuke, Niikura, Takahiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10173009/
https://www.ncbi.nlm.nih.gov/pubmed/37180736
http://dx.doi.org/10.1016/j.jbo.2023.100478

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10173009/
https://www.ncbi.nlm.nih.gov/pubmed/37180736
http://dx.doi.org/10.1016/j.jbo.2023.100478

Ejemplares similares